Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Shumaker

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|January 1, 1977
Pulmonary heart disease induced by disenecioyl dehydroretronecine: a semisynthesis pyrrolizidine alkaloid pyrroleR C Shumaker, T J Raczniak, W D Johnson, et al.
Archives of Pathology & Laboratory Medicine|February 1, 1977
Fibrin thrombosis in monocrotaline pyrrole-induced cor pulmonale in ratsJ L Lalich, W D Johnson, T J Raczniak, et al.
Respiration; International Review of Thoracic Diseases|January 1, 1979
Pathophysiology of dehydromonocrotaline-induced pulmonary fibrosis in the beagleT J Raczniak, R C Shumaker, J R Allen, et al.
Therapeutic Drug Monitoring|February 1, 1994
Simultaneous determination of felbamate, primidone, phenobarbital, carbamazepine, two carbamazepine metabolites, phenytoin, and one phenytoin metabolite in human plasma by high-performance liquid chromatographyL A Romanyshyn, J K Wichmann, N Kucharczyk, et al.
Epilepsia|August 1, 1997
Tolerability and pharmacokinetics of monotherapy felbamate doses of 1,200-6,000 mg/day in subjects with epilepsyR Sachdeo, S K Narang-Sachdeo, R C Shumaker, et al.
Journal of Clinical Pharmacology|April 29, 1998
Evaluation of the potential interaction between felbamate and erythromycin in patients with epilepsyR C Sachdeo, S Narang-Sachdeo, P A Montgomery, et al.
Epilepsia|August 17, 1999
Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamateR Sachdeo, M L Wagner, S Sachdeo, et al.
Clinical Pharmacology and Therapeutics|November 1, 1994
The effect of felbamate on valproic acid dispositionM L Wagner, N M Graves, I E Leppik, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|January 1, 1977
Pulmonary heart disease induced by disenecioyl dehydroretronecine: a semisynthesis pyrrolizidine alkaloid pyrroleR C Shumaker, T J Raczniak, W D Johnson, et al.
Archives of Pathology & Laboratory Medicine|February 1, 1977
Fibrin thrombosis in monocrotaline pyrrole-induced cor pulmonale in ratsJ L Lalich, W D Johnson, T J Raczniak, et al.
Respiration; International Review of Thoracic Diseases|January 1, 1979
Pathophysiology of dehydromonocrotaline-induced pulmonary fibrosis in the beagleT J Raczniak, R C Shumaker, J R Allen, et al.
Therapeutic Drug Monitoring|February 1, 1994
Simultaneous determination of felbamate, primidone, phenobarbital, carbamazepine, two carbamazepine metabolites, phenytoin, and one phenytoin metabolite in human plasma by high-performance liquid chromatographyL A Romanyshyn, J K Wichmann, N Kucharczyk, et al.
Epilepsia|August 1, 1997
Tolerability and pharmacokinetics of monotherapy felbamate doses of 1,200-6,000 mg/day in subjects with epilepsyR Sachdeo, S K Narang-Sachdeo, R C Shumaker, et al.
Journal of Clinical Pharmacology|April 29, 1998
Evaluation of the potential interaction between felbamate and erythromycin in patients with epilepsyR C Sachdeo, S Narang-Sachdeo, P A Montgomery, et al.
Epilepsia|August 17, 1999
Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamateR Sachdeo, M L Wagner, S Sachdeo, et al.
Clinical Pharmacology and Therapeutics|November 1, 1994
The effect of felbamate on valproic acid dispositionM L Wagner, N M Graves, I E Leppik, et al.
Pageof 2